Novartis to Acquire Cadent for up to $770 Million
Novartis has agreed to acquire U.S. based neuroscience company Cadent for up to $770 million, according to press release. Cadent will receive $210 million upfront payment and will be eligible…
Novartis has agreed to acquire U.S. based neuroscience company Cadent for up to $770 million, according to press release. Cadent will receive $210 million upfront payment and will be eligible…
Roche has announced a partnership with Moderna to use its Elecsys Anti-SARS-CoV-2 S antibody test in Moderna's mRNA-1273 vaccine trials, according to Roche’s press release. Roche's anti-SARS-CoV-2 antibody test detects…
The U.S. Food and Drug Administration has granted Roche an emergency use authorization (EUA) for Elecsys Anti-SARS-CoV-2 S test, according to Roche’s press release. The test will gauge an individual’s…